Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Comment by CUR2004on May 09, 2004 9:47pm
280 Views
Post# 7462527

RE: look

RE: lookLook at this... Day 2 – Thurs, May 13, 2004 --- 11:00 AM DiagnoCure Inc. https://www.biofinance.ca/main.cfm?docID=88&title=Conference%20Preview&subTitle=Presentation%20Schedule I think we will see the first analyst report Thursday....Look at the mission of BioFinance. *** Our Objectives Are: EXPLORE opportunities for investment in 100 Canadian, US and European life science companies. These firms are in all stages of development, from large publicly traded companies through to major private companies and early-stage seed opportunities. DISCOVER creative financing techniques used by the most innovative biopharmaceutical companies to fund operating requirements in today's market environment. NETWORK with investors from institutions, merchant banks, pension funds, mutual funds, venture capital and early stage funds. DEVELOP innovative and effective business strategies to cope with the challenges of the next millennium. MEET senior executives, professional service providers, scientists and clinicians involved in the biopharmaceutical industry CUR2004
Bullboard Posts